Spots Global Cancer Trial Database for RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
Official Title: Prospective Controlled Randomized Comparative Study About Quality of Life (QoL), Immunomodulation and Safety of Adjuvant Mistletoe Treatment in Patients With Gastric Carcinoma Receiving Chemotherapy After Operation
Study ID: NCT01401075
Conditions
Study Description
Brief Summary: Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
ASAN Medical Center, Seoul, , Korea, Republic of
Contact Details
Name: Byung-Sik Kim, Professor
Affiliation: ASAN Medical Center, Seoul
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
